Vonjo (pacritinib) improves hemoglobin levels in myelofibrosis patients with anemia, aligning with clinical guidelines for anemia management. The study showed 44% of patients achieved a hemoglobin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results